Comparing Individualized vs. Weight Based Protocols to Treat VOE in SCD Occlusive Episodes in Sickle Cell Disease

Condition:   Sickle Cell Disease
Interventions:   Other: Patient-Specific Protocol;   Other: Weight-based Protocol;   Drug: Morphine;   Drug: Hydromorphone
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days